Pacific Biosciences of California Inc., up $3.05 to $7.56. The genetic analysis technology company agreed to be bought by genetic testing tools maker ...
News
- Apple and Kraft Heinz drop while Starbucks and Symantec rise
- Initial public offerings scheduled to debut next week
Business: Phase 3 biotech developing small molecule therapies for Alzheimer's disease. CNFinance Holdings - 6.5 million shares, priced $7.50-$8.50 ...
- Texas Biomed CEO charting global course for SA institute
The New Jersey native believes San Antonio can be a global center for infectious disease research with new investment in Texas Biomed's campus.
- Radius Health: 3Q Earnings Snapshot
The biotechnology company posted revenue of $27.6 million in the period, which beat Street forecasts. Three analysts surveyed by Zacks expected ...
- Agena Launches Bone Marrow Engraftment Assay For Chimerism Analysis
1, 2018 /PRNewswire/ -- Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the Chimeric ID Panel ...